Trevi Therapeutics Inc (NASDAQ:TRVI) The 4 analysts offering 12-month price forecasts for Trevi Therapeutics Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +229.22% increase from the last price of 2.43.